Group I (n = 52) | Group II (n = 21) | p value | |
---|---|---|---|
Creatinine concentration after the surgery (mg/dl) | 1.19 (0.7-2.6) | 1.15 (1-1.31) | 0.91 |
Positive surgical margin | 9 (17,3%) | 0 | 0.04 |
Mean number of lymph nodes dissected | 20,2 | 19,6 | 0,83 |
Local relapse | 2 (3.8%) | 1 (4.7%) | 0.85 |
Distant metastases after operation | 5 (9.6%) | 2 (9.4%) | 0.37 |
Adjuvant chemotherapy | 26 (50%) | 3 (14,2%) | 0,04 |
Postoperative complications | 5 (9.6%) | 0 | 0.14 |
Death (cancer-specific) | 15 (28.8%) | 2 (9.5%) | 0.07 |
Follow-up (months) | 60.5 (0-76) | 83.6 (9-181) | 0.09 |